13F Holdings
中文EN

VSEE VSEE HEALTH, INC.

Services-Health Services · OTC · SEC CIK 1864531 · Fiscal year ends 12/31

Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY9.0%
TTM net income YoY81.1%
TTM EPS YoY96.1%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin42.1%
Operating margin-88.4%
Net margin-98.9%
FCF margin-50.8%
EBITDA margin-68.0%

Returns

ROE-1,345.0%
ROA-71.5%
ROIC (approx.)-412.2%
Asset turnover0.72x

Leverage & solvency

Liabilities / assets54.6%
Debt / equity0.15x
Current ratio0.40x
Interest coverage-5.69x

Cash quality & payout

Operating cash flow / net income0.51x
Accruals ratio-35.4%
Payout ratio—
Capex / revenue0.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31
Income statement
Revenue$14.62M$10.42M$5.77M—
Cost of revenue$7.26M$3.24M$1.93M—
Gross profit$7.36M$7.18M$3.83M—
SG&A expense$10.04M$6.55M$1.20M—
Operating income-$9.58M-$62.15M-$1.87M-$3.59M
Interest expense$2.81M$211,459$191,323$125,980
Pretax income-$14.64M-$59.34M-$1.89M-$3.06M
Income tax$68,426-$1.64M$1.84M$187,225
Net income-$14.71M-$57.70M-$3.76M-$3.24M
EBITDA-$7.00M-$60.83M-$1.87M—
EPS (basic)-0.73-5.65-0.38-0.25
EPS (diluted)-0.73-5.65-0.38-0.25
Weighted avg. shares (diluted)20.14M10.21M10.00M12.74M
Balance sheet
Cash & equivalents$5.05M$326,115$118,734$230,664
Receivables$2.24M$1.72M$603,480—
Current assets$8.37M$3.02M$802,134$106,998
PP&E, net$294,987$680,242$3,657—
Goodwill$4.92M$4.92M——
Intangibles$8.79M$10.99M$0—
Total assets$22.41M$19.99M$805,791$7.63M
Current liabilities$16.24M$19.01M$5.11M$3.30M
Short-term debt$880,175$433,983$220,000—
Long-term debt$593,941$593,941$220,000—
Total debt$1.47M$1.03M$440,000—
Total liabilities$16.96M$20.01M$5.11M$7.67M
Shareholders' equity$5.45M-$18,488-$12.27M-$7.43M
Net debt-$3.58M$701,809$321,266—
Shares outstanding33.19M16.30M4.64M—
Cash flow statement
Operating cash flow-$3.45M-$5.79M-$632,595-$1.39M
Capital expenditure$29,928$55,267$4,335—
Free cash flow-$3.48M-$5.84M-$636,930—
Investing cash flow-$29,928-$26,144-$4,335$110.12M
Financing cash flow$8.42M$6.02M$525,000-$109.38M
Depreciation & amortization$2.59M$1.32M$678—
Stock-based compensation$1.12M$896,537$0—
Share buybacks$44$5,150$6.80M$110.47M

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.